Conferences & Events

We invite you to meet with us at the world’s most comprehensive hematology event of the year. The 63rd ASH Annual Meeting will provide an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology. It’s a great opportunity to discuss the benefits for your trial of the clinical oncology landscape in Canada…

Julie Martin, Scimega CEO & Co-Owner looks to the future and how to identify key operational process and adaptations to help US sponsors optimally navigate the ‘new normal’ in clinical trial operations in Canada and other geographic areas. Julie shares strategies for how to leverage lessons learned in 2020 and put these into action to maximize clinical development progress in 2021-22.

SITC 2021 is the leading destination for scientific exchange, education and networking in the immunotherapy field. A great opportunity to discuss the benefits for your trial of the clinical oncology landscape in Canada…

Julie Martin, Scimega CEO & Co-Owner looks to the future and how to identify key operational process and adaptations to help US sponsors optimally navigate the ‘new normal’ in clinical trial operations in Canada and other geographic areas. Julie shares strategies for how to leverage lessons learned in 2020 and put these into action to maximize clinical development progress in 2021-22.

Julie Martin, Scimega CEO & co-Owner, looks to the future and how to identify key operational process and adaptations to help US sponsors optimally navigate the ‘new normal’ in clinical trial operations in Canada and other geographic areas. Julie shares strategies for how to leverage lessons learned in 2020 and put these into action to maximize clinical development progress in 2021-22.